What is the recommended dose of cefixime (cephalosporin antibiotic) for a 9-month-old infant with pneumonia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 30, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Cefixime is NOT Recommended for Pneumonia in a 9-Month-Old Infant

Amoxicillin 90 mg/kg/day divided into 2 doses is the preferred first-line treatment for community-acquired pneumonia in a 9-month-old infant, not cefixime. 1, 2

Why Cefixime Should Not Be Used

  • Cefixime is not listed as a recommended agent for pneumonia treatment in the authoritative IDSA/PIDS pediatric pneumonia guidelines 1
  • The FDA label for cefixime specifically lists approved indications as otitis media, pharyngitis/tonsillitis, acute exacerbations of chronic bronchitis, and uncomplicated gonorrhea—pneumonia is notably absent from this list 3
  • While one older study from 1987 evaluated cefixime for pneumonia, it only included 5 patients with pneumonia (all with "possible pathogens"), making this insufficient evidence to support its use 4

Correct First-Line Treatment

  • Prescribe oral amoxicillin 90 mg/kg/day divided into 2 doses for outpatient treatment of community-acquired pneumonia in this 9-month-old 1, 2
  • This high-dose regimen specifically targets penicillin-resistant Streptococcus pneumoniae, the most common bacterial cause of pneumonia in this age group 1, 2
  • Treatment duration should be 5-7 days, with reassessment if symptoms persist beyond 48-72 hours 2

Alternative Agents When Amoxicillin Cannot Be Used

For β-lactamase-producing organisms (if suspected):

  • Amoxicillin-clavulanate 90 mg/kg/day (amoxicillin component) divided into 2 doses is the preferred alternative 1, 5
  • Maximum daily dose is 4000 mg of the amoxicillin component 5

For non-type 1 penicillin allergy:

  • Second- or third-generation oral cephalosporins can be considered, including cefpodoxime, cefuroxime, or cefprozil 1
  • Cefdinir is mentioned as an alternative alongside cefixime, cefpodoxime, and ceftibuten specifically for β-lactamase-producing Haemophilus influenzae when amoxicillin-clavulanate cannot be used 6
  • However, these are not first-line agents and have inferior pneumococcal coverage compared to high-dose amoxicillin 6, 2

For type 1 hypersensitivity to β-lactams:

  • Azithromycin or clarithromycin should be used instead 2

Critical Clinical Pitfall

  • Do not substitute cefixime for amoxicillin in pneumonia treatment—the evidence base is inadequate, it is not guideline-recommended, and it provides suboptimal coverage for S. pneumoniae, the primary pathogen 1, 2, 3
  • The one comparative study showing cefixime efficacy used it as step-down therapy after initial parenteral ceftriaxone, not as primary monotherapy 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Amoxicillin Dosing for Community-Acquired Pneumonia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Maximum Dose of Augmentin for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Cefdinir Dosing Guidelines for Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.